
Visicellmedical
Offers cell labeling solutions to allow scientists to trace the precise sites of CAR-T and stem cell treatment products.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor investor | €0.0 | round | |
* | $260k | Grant | |
Total Funding | 000k |
Related Content
Visicell Medical specializes in providing advanced cell labeling solutions that enable scientists to accurately track the locations of CAR T, NK, and stem cell therapies after administration. Operating in the biotechnology and healthcare sectors, Visicell serves researchers and medical professionals who are focused on cell-based therapies. The company’s core technology offers non-toxic, easy-to-use, and cost-effective labeling options, effectively acting as a 'GPS for cell therapy.' This technology accelerates the introduction of cell-based therapies to the market by providing real-time insights into cell locations, thereby enhancing the success rates of these treatments. Visicell generates revenue through the sale of its proprietary labeling products and ongoing technological upgrades. The business model focuses on continuous innovation and customer support to maintain a competitive edge in the rapidly evolving field of cell therapy.
Keywords: cell labeling, CAR T therapy, stem cell tracking, biotechnology, healthcare, non-toxic solutions, real-time insights, GPS for cells, immune cell labeling, theranostic nanomaterials.